Ken Griffin Mannkind Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Mannkind Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 64,300 shares of MNKD stock, worth $424,380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,300
Previous 203,700
68.43%
Holding current value
$424,380
Previous $922,000
63.67%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding MNKD
# of Institutions
219Shares Held
133MCall Options Held
1.43MPut Options Held
851K-
Black Rock Inc. New York, NY22.6MShares$149 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$102 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$66.5 Million5.97% of portfolio
-
State Street Corp Boston, MA9.56MShares$63.1 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.76MShares$57.8 Million0.62% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.7B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...